Citurgia Biochemicals Ltd
Citurgia Biochemicals is engaged in manufactures citric acid, calcium carbonate and plasticizers. Citric acid is traditionally used in foods, soft drinks, confectionary and drugs. It is also used in chemicals, where it provides stable pH conditions for polyester and nylon. Acrylic print curing and cotton- resist printing.(Source : 201903 Annual Report Page No:62)
- Market Cap ₹ Cr.
- Current Price ₹ 31.6
- High / Low ₹ /
- Stock P/E
- Book Value ₹ -0.53
- Dividend Yield 0.00 %
- ROCE -2,150 %
- ROE %
- Face Value ₹ 2.00
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
0.17 | 0.18 | 0.16 | 0.10 | 0.18 | 0.24 | 0.12 | 0.37 | 0.18 | 0.21 | 0.25 | 0.20 | |
Operating Profit | -0.17 | -0.18 | -0.16 | -0.10 | -0.18 | -0.24 | -0.12 | -0.37 | -0.18 | -0.21 | -0.25 | -0.20 |
OPM % | ||||||||||||
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.67 | 0.58 | 0.50 | 0.43 | 0.37 | 0.32 | 0.28 | 0.24 | 0.23 | 0.23 | 0.23 | 0.23 |
Profit before tax | -0.84 | -0.76 | -0.66 | -0.53 | -0.55 | -0.56 | -0.40 | -0.61 | -0.41 | -0.44 | -0.48 | -0.43 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
-0.84 | -0.76 | -0.66 | -0.54 | -0.55 | -0.56 | -0.40 | -0.61 | -0.40 | -0.44 | -0.48 | -0.42 | |
EPS in Rs | -0.06 | -0.06 | -0.05 | -0.04 | -0.04 | -0.04 | -0.03 | -0.05 | -0.03 | -0.03 | -0.04 | -0.03 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | 4% |
5 Years: | -1% |
3 Years: | -2% |
TTM: | 13% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 |
Reserves | -27.59 | -28.35 | -29.01 | -29.55 | -30.10 | -30.66 | -31.06 | -31.67 | -32.08 | -32.51 | -32.99 | -33.41 |
4.47 | 4.49 | 4.50 | 5.15 | 6.45 | 6.48 | 6.48 | 6.49 | 6.49 | 6.55 | 6.77 | 6.83 | |
7.92 | 8.59 | 9.67 | 9.93 | 10.05 | 10.13 | 10.13 | 10.36 | 10.60 | 10.73 | 10.84 | 10.92 | |
Total Liabilities | 11.22 | 11.15 | 11.58 | 11.95 | 12.82 | 12.37 | 11.97 | 11.60 | 11.43 | 11.19 | 11.04 | 10.76 |
4.24 | 3.66 | 3.16 | 2.73 | 2.36 | 2.04 | 1.76 | 1.52 | 1.30 | 1.07 | 0.85 | 0.62 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
6.98 | 7.49 | 8.42 | 9.22 | 10.46 | 10.33 | 10.21 | 10.08 | 10.13 | 10.12 | 10.19 | 10.14 | |
Total Assets | 11.22 | 11.15 | 11.58 | 11.95 | 12.82 | 12.37 | 11.97 | 11.60 | 11.43 | 11.19 | 11.04 | 10.76 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.11 | -0.03 | -0.08 | -0.51 | -1.32 | -0.19 | -0.11 | -0.15 | -0.03 | -0.07 | -0.14 | -0.12 | |
0.00 | 0.00 | 0.00 | 0.13 | -0.07 | 0.02 | 0.06 | 0.15 | 0.01 | 0.04 | -0.05 | 0.07 | |
0.00 | 0.00 | 0.00 | 0.65 | 1.30 | 0.03 | 0.00 | 0.01 | 0.00 | 0.06 | 0.22 | 0.06 | |
Net Cash Flow | 0.11 | -0.03 | -0.08 | 0.27 | -0.09 | -0.15 | -0.06 | 0.01 | -0.01 | 0.02 | 0.03 | 0.01 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | ||||||||||||
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | ||||||||||||
Working Capital Days | ||||||||||||
ROCE % | -22.58% | -25.94% | -29.53% | -26.97% | -22.96% | -22.36% | -19.61% | -39.61% | -39.61% | -68.22% | -145.45% | -2,150.00% |
Documents
Announcements
- Results-Delay in Financial Results 9 Jun
-
Board Meeting Intimation for Consider And Approve Audited Financial Result For The Quarter And Year Ended On 31.03.2025
24 May - Board meeting on May 30, 2025, to approve audited financial results for quarter and year ended March 31, 2025.
-
Auditor Report As Per SEBI Prescribed Format (Refer SEBI Circular CIR/CFD/CMD1/80/2019 Dated July 19, 2019) For The Quarter And Year Ended On 31St March, 2024.
22 May - Submission of auditor report for FY 2023-24 as per SEBI format.
-
Auditor Report As Per SEBI Prescribed Format (Refer SEBI Circular
CIR/CFD/CMD1/80/2019 Dated July 19, 2019) For The Quarter And Year Ended On 31St March, 2024.
19 May - Submission of auditor report for FY 2023-24 quarter and year ended March 31, 2024.
-
Intimation Regarding Approval Letter Received From Stock Exchange For Re-Classification Of Promoters/Promoter Group Category To Public Category
19 May - BSE approved reclassification of promoters' shares to public category, promoter holding now 99.36%.